Proteomic clusters underlie heterogeneity in preclinical Alzheimer's disease progression. Wisch JK, Butt OH, Gordon BA, Schindler SE, et al. Brain 2022 Dec 21:awac484. doi: 10.1093.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Wisch JK, Butt OH, Gordon BA, Schindler SE, et al. Proteomic clusters underlie heterogeneity in preclinical Alzheimer's disease progression. Brain 2022 Dec 21:awac484. doi: 10.1093.
PMID: 36542469